Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 9,832 | 8,206 | 6,832 | 32,521 | 3,664 |
| Cost of Goods | 612 | 776 | 234 | 925 | 431 |
| Gross Profit | 9,220 | 7,430 | 6,598 | 31,596 | 3,233 |
| Operating Expenses | 44,489 | 45,409 | 46,390 | 44,015 | 42,845 |
| Operating Income | -34,657 | -37,203 | -39,558 | -11,494 | -39,181 |
| Interest Expense | 2,530 | 2,746 | 2,876 | 3,257 | 3,331 |
| Other Income | -613 | 0 | 0 | 0 | 103,387 |
| Pre-tax Income | -37,800 | -39,949 | -42,434 | -14,751 | 60,875 |
| Income Tax | 0 | N/A | N/A | N/A | 3,789 |
| Net Income Continuous | -37,800 | -39,949 | -42,434 | -10,962 | 57,086 |
| Net Income | $-37,800 | $-39,949 | $-42,434 | $-10,962 | $57,086 |
| EPS Basic Total Ops | -1.92 | -2.04 | -2.19 | -0.54 | 2.96 |
| EPS Basic Continuous Ops | -1.92 | -2.04 | -2.19 | -0.55 | 2.96 |
| EPS Diluted Total Ops | -1.92 | -2.04 | -2.19 | -0.48 | 2.90 |
| EPS Diluted Continuous Ops | -1.92 | -2.04 | -2.19 | -0.49 | 2.91 |
| EPS Diluted Before Non-Recurring Items | -1.89 | -2.04 | -2.19 | -0.57 | -1.26 |
| EBITDA(a) | $-31,733 | $-34,287 | $-36,648 | $-8,212 | $-35,836 |